We are live on ! Find out more
BE

Bonness Enterprises Portfolio holdings

AUM $310M
1-Year Est. Return 24.22%
This Fund
S&P 500
This Quarter Est. Return
+11.69%
1 Year Est. Return
+24.22%
3 Year Est. Return
+94.56%
5 Year Est. Return
+137.52%
10 Year Est. Return
+441.57%
AUM
$217M
AUM Growth
+$20.4M
Cap. Flow
-$925K
Cap. Flow %
-0.43%
Top 10 Hldgs %
63.58%
Holding
41
New
1
Increased
7
Reduced
8
Closed

Top Buys

Rank Stock Value
1
OGN icon
Organon & Co
OGN
+$1.47M
2
VZ icon
Verizon
VZ
+$553K
3
VTRS icon
Viatris
VTRS
+$142K
4
PFE icon
Pfizer
PFE
+$129K
5
BMY icon
Bristol-Myers Squibb
BMY
+$99.7K

Top Sells

Rank Stock Value
1
PGR icon
Progressive
PGR
+$3.07M
2
IBM icon
IBM
IBM
+$170K
3
MSFT icon
Microsoft
MSFT
+$64.8K
4
KO icon
Coca-Cola
KO
+$55.7K
5
NUE icon
Nucor
NUE
+$54.7K

Sector Composition

Rank Sector Weight
1 Financials 30.67%
2 Healthcare 29.96%
3 Technology 25.18%
4 Consumer Staples 3.96%
5 Industrials 3.91%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PGR icon
1
Progressive
PGR
$122B
$58.9M 27.2%
573,653
-32,200
-5% -$3.07M
SYK icon
2
Stryker
SYK
$128B
$18.3M 8.44%
68,366
-34
-0% -$8.92K
MSFT icon
3
Microsoft
MSFT
$3.59T
$15.5M 7.18%
46,200
-200
-0.4% -$64.8K
AAPL icon
4
Apple
AAPL
$4.48T
$9.76M 4.51%
54,940
TMO icon
5
Thermo Fisher Scientific
TMO
$214B
$7.61M 3.51%
11,400
JNJ icon
6
Johnson & Johnson
JNJ
$609B
$6.68M 3.08%
39,038
+100
+0.3% +$16.4K
NUE icon
7
Nucor
NUE
$58.5B
$5.35M 2.47%
46,850
-500
-1% -$54.7K
MRK icon
8
Merck
MRK
$317B
$5.33M 2.46%
69,500
CSCO icon
9
Cisco
CSCO
$455B
$5.24M 2.42%
82,700
-200
-0.2% -$11.4K
ABBV icon
10
AbbVie
ABBV
$435B
$5M 2.31%
36,900
+300
+0.8% +$35.4K
AMAT icon
11
Applied Materials
AMAT
$408B
$4.92M 2.27%
31,300
PFE icon
12
Pfizer
PFE
$143B
$4.79M 2.21%
81,208
+2,600
+3% +$129K
ABT icon
13
Abbott
ABT
$185B
$4.6M 2.13%
32,700
INTC icon
14
Intel
INTC
$457B
$4.58M 2.12%
88,950
MRSH
15
Marsh
MRSH
$91.4B
$4.47M 2.06%
25,700
-100
-0.4% -$16.6K
UL icon
16
Unilever
UL
$137B
$4.09M 1.89%
67,591
EMR icon
17
Emerson Electric
EMR
$85.4B
$4.04M 1.87%
43,500
IBM icon
18
IBM
IBM
$213B
$3.94M 1.82%
29,464
-1,355
-4% -$170K
BMY icon
19
Bristol-Myers Squibb
BMY
$133B
$3.42M 1.58%
54,800
+1,700
+3% +$99.7K
UPS icon
20
United Parcel Service
UPS
$90.6B
$3.2M 1.48%
14,950
GSK icon
21
GSK
GSK
$103B
$2.92M 1.35%
52,960
+1,600
+3% +$83.2K
A icon
22
Agilent Technologies
A
$39.2B
$2.86M 1.32%
17,900
WLY icon
23
John Wiley & Sons Class A
WLY
$2.67B
$2.77M 1.28%
48,400
PG icon
24
Procter & Gamble
PG
$337B
$2.68M 1.24%
16,400
VZ icon
25
Verizon
VZ
$198B
$2.47M 1.14%
47,587
+10,600
+29% +$553K

Similar funds

Bonness Enterprises's Q4 2021 Portfolio in Review

As of Q4 2021, Bonness Enterprises held 41 positions worth $217M, up 10% from $196M the previous quarter. Its ten largest holdings account for 64% of the portfolio.

Trading was light in Q4 2021: portfolio turnover was 2.4%. Bonness Enterprises opened 1 new position and made no exits, leaving the 41-position portfolio largely intact.

By sector, the portfolio is most concentrated in Financials at 31% of assets, down from 31% a quarter earlier, followed by Healthcare and Technology.

  • Bonness Enterprises's largest Q4 2021 buy was Viatris: 10,637 shares worth $144K.
  • Bonness Enterprises added most to Organon & Co in Q4 2021, an estimated $1.47M increase.
  • Bonness Enterprises's biggest Q4 2021 reduction was Progressive, cutting an estimated $3.07M.
  • Bonness Enterprises's ten largest holdings make up 64% of its $217M portfolio in Q4 2021.
  • Bonness Enterprises opened 1 new position and closed 0 in Q4 2021.
  • Bonness Enterprises's portfolio value rose 10% quarter-over-quarter to $217M.

Based on Bonness Enterprises's 13F filing for Q4 2021, filed 13 Jan 2022.